Obesity, cardiovascular risk factor;Obesidad, factor de riesgo cardiovascular

Revista Espanola de Obesidad

Volumn 3, Issue 2, 2005, Pages 89-94

  Zugasti Murillo, Ana ^a,b   Moreno Esteban, Basilio ^a  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33646857256     PISSN: 16966112     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (13)

1. McGinnis JM, Foege WH. Actual causes of death in the United States. JAMA 1993; 270: 2207-12.
2. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA 2003; 289: 187-93.
3. Kim KS, Owen WL, Williams D, Adams-Campbell LL. A comparison between BMI and Conicity index on predicting coronary heart disease: the Framingham Heart Study. Ann Epidemiol 2000; 10: 424-31.
4. Clausen JO, Hansen I, Bjorbaek C, Echwald SM, Urhammer S, Andersen CB, et al. Insulin resistance: interactions between obesity and a common variant of insulin receptor sustrate-1. Lancet 1995; 346: 397-402.
5. Hu G, Qiao Q, Tuomilehto J, Balkau B, Borch-Johnsen K, Pyorala K. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic european men and women. Arch Intern Med 2004; 164: 1066-76.
6. Gonzalez Albarrán O, García Robles R. Obesidad como factor de riesgo cardiovascular. Obesidad, la epidemia del siglo XXI. Madrid: Internacional de Ediciones y Publicaciones 1999: cap 12: 191-209.
7. Engeli S, Sharma AM. Emerging concepts in the phatophysiology and treatment of obesity associated hypertension. Curr Opin Cardiol 2002; 17: 355-9.
8. Manson JE, Willet WC, Stampfer MJ, Colditz GA, Hunter DJ, Hankinson SE, et al. Body weight and mortality among women. N Engl J Med 1995; 333: 677-85.
9. Colditz GA, Willet WC, Stampfer MJ, Manson JE, Hennekens CH, Arky RA, et al. Weight as a risk factor for clinical diabetes in women. Am J Epidemiol 1990; 132: 501-13.
10. Albu J, Raja-Khan N. The management of the obese diabetic patient. Prime Care Clin Office Pract 2003; 30: 465-91.
11. Torgerson JS, Hauptman J, Boldrin MN, Söström L. XENical in the prevention of diabetes in obeses subjects (XENDOS) Study. A study of orlistat as an adjunt to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care 2004; 27: 155-61.
12. Aranceta J, Foz M, Gil B, Jover E, Mantilla T, Millán J, et al. Obesidad y riesgo cardiovascular. Estudio DORICA. Editorial Médica Panamericana: Madrid, 2004.
13. Sowers JR, FACP, FAHA. Obesity as a cardiovascular risk factor. Am J Med 2003; 115: 37S-41S.